Truist Securities analyst Jailendra Singh raised the price target on Hims and Hers (NYSE: HIMS) to $39.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1.21 puts on 427K contractsFebruary 26, 2025 5:07 AM Hims and Hers (HIMS) PT Raised to $44 at TD CowenFebruary 25, 2025 4:35 PM Hims and Hers (HIMS) PT Raised to $35 at Piper Sandler; 'Wide Range Of Future Outcomes Keeps Us On Sidelines'February 25, 2025 7:43 AM Novo shares rise as HIMS halt sales of some obesity drugsFebruary 25, 2025 7:21 AM Hims and Hers (HIMS) PT Raised to $40 at Leerink PartnersFebruary 25, 2025 6:29 AM Hims and Hers (HIMS) PT Raised to $61 at NeedhamFebruary 25, 2025 6:07 AM Leerink Partners Reiterates Market Perform Rating on Hims and Hers (HIMS)February 25, 2025 5:36 AM Morgan Stanley Reiterates Equalweight Rating on Hims and Hers (HIMS)February 25, 2025 5:35 AM Truist Securities Reiterates Hold Rating on Hims and Hers (HIMS)February 25, 2025 5:34 AM BofA Securities Reiterates Underperform Rating on Hims and Hers (HIMS), PT $21February 25, 2025 5:17 AM BTIG Reiterates Buy Rating on Hims and Hers (HIMS)February 25, 2025 5:11 AM